Free cold-chain shipping on orders €99+Use code PX10 for 10% off your first order
New
Survodutide 10 mg research vial, ≥ 99.1% HPLC purity
Survodutide 10 mg research vial — Lyophilized powder · 3 mL amber vial, batch SV-2441-R, verified ≥ 99.1% purity by HPLC.
HPLC ≥ 99.1%MS verifiedEndotoxin screened
Research reference

Survodutide

Dual GCGR/GLP-1 receptor agonist analogue

Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist studied in hepatic lipid metabolism and energy-expenditure models. Supplied as a 10 mg lyophilized fill at ≥ 99.1% HPLC purity with dual-receptor identity documentation.

  • Dual GCGR/GLP-1 identity documentation
  • Purity ≥ 99.1% by HPLC
  • Sterile lyophilized format
  • The glucagon counterpart to GLP-1 research lines
€1841

88 vials of 10 mg in current lot · ships in 24 h cold-chain

FormatLyophilized powder · 3 mL amber vial
Net content10 mg
CAS1358161-76-4
Molar mass5003.5 g/mol
Purity (HPLC)≥ 99.1%
StorageStore at –20 °C. Cold-chain shipment included.
Pairs well with

Related references

Bestseller≥ 99.2%
Semaglutide 5 mg research vial, ≥ 99.2% HPLC purity
Metabolic & GLP-1

Semaglutide

5 mg · 10 mg

GLP-1 research reference with full identity package

from€68 / vial
New≥ 99.1%
Tirzepatide 10 mg research vial, ≥ 99.1% HPLC purity
Metabolic & GLP-1

Tirzepatide

10 mg · 20 mg

Dual-incretin reference for next-gen metabolic panels

from€95.50 / vial
≥ 99.0%
AOD-9604 5 mg research vial, ≥ 99.0% HPLC purity
Metabolic & GLP-1

AOD-9604

2 mg · 5 mg · 10 mg

Adipose-model research workhorse

from€25.93 / vial